Holen Sie sich die Stockscreener-App
0.088
34.38%
-0.0461
Handel nachbörslich:
.06
-0.028
-31.82%
Schlusskurs vom Vortag:
$0.1341
Offen:
$0.1119
24-Stunden-Volumen:
6.68M
Relative Volume:
12.22
Marktkapitalisierung:
$12.39M
Einnahmen:
$12.00M
Nettoeinkommen (Verlust:
$-63.23M
KGV:
-0.0147
EPS:
-6
Netto-Cashflow:
$-43.02M
1W Leistung:
-82.04%
1M Leistung:
-84.29%
6M Leistung:
-95.34%
1J Leistung:
-90.12%
1-Tages-Spanne:
$0.0725
$0.1119
1-Wochen-Bereich:
$0.0725
$0.51
52-Wochen-Spanne:
$0.0725
$2.09
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Firmenname
Accelerate Diagnostics Inc
Sektor
Branche
Telefon
303-863-8088
Adresse
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Vergleichen Sie AXDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
0.088 | 12.39M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-09 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-10-08 | Eingeleitet | BTIG Research | Neutral |
| 2020-08-07 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-09-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-05-24 | Eingeleitet | Craig Hallum | Hold |
| 2017-12-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-07-12 | Fortgesetzt | BTIG Research | Buy |
| 2016-03-24 | Eingeleitet | JP Morgan | Overweight |
| 2015-12-16 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Accelerate Diagnostics Inc Aktie (AXDX) Neueste Nachrichten
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics, Inc.(NasdaqCM: AXDX) dropped from S&P TMI Index - marketscreener.com
Accelerate Diagnostics Files for Chapter 11 Bankruptcy - TipRanks
Accelerate Diagnostics files for Chapter 11 bankruptcy, seeks asset sale amid financial strain - ABC15 Arizona
Accelerate Diagnostics (AXDX) to Release Earnings on Wednesday - Defense World
Arizona-Based Accelerate Diagnostics Files for Bankruptcy, Plans Asset Sale - NewsBreak: Local News & Alerts
Post-Trade Analysis: Accelerate Diagnostics Inc (AXDX) Slides -70.39, Closing at 0.14 - DWinneX
Accelerate Diagnostics initiates Chapter 11 and asset sale By Investing.com - Investing.com Nigeria
Accelerate Diagnostics files for Chapter 11 - USA Herald
Biotech Co. Accelerate Diagnostics Hits Ch. 11 With Sale Plan - Law360
Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets - marketscreener.com
Accelerate Diagnostics (AXDX) Starts Chapter 11 for Asset Sale | - GuruFocus
Accelerate Diagnostics Initiates Chapter 11 Restructuring Proceeding - Nasdaq
Accelerate Diagnostics initiates Chapter 11 and asset sale - Investing.com
Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - Stock Titan
Accelerate Diagnostics files for Chapter 11 bankruptcy - marketscreener.com
Motion for Joint Administration Filed by Accelerate Diagnostics, Inc. - marketscreener.com
Accelerate Diagnostics, Inc. Filed for Bankruptcy - marketscreener.com
Renaissance Technologies LLC Grows Position in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Short Interest Update - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Raymond James Has Negative Forecast for TSE:BEI Q1 Earnings - The AM Reporter
Accelerate Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com - Defense World
Accelerate Diagnostics grants CEO retention bonus - Investing.com Australia
Accelerate Diagnostics grants CEO retention bonus By Investing.com - Investing.com Canada
Accelerate Diagnostics CEO Retention Bonus Agreement - TipRanks
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Sees Significant Decrease in Short Interest - Defense World
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - The Manila Times
Renovaro Secures High-Powered Computing from Nebul Through - GlobeNewswire
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight - GlobeNewswire
Accelerate Diagnostics adds new independent directors - Investing.com Australia
Accelerate Diagnostics adds new independent directors By Investing.com - Investing.com Canada
Accelerate Diagnostics (AXDX) Appoints New Directors and Forms S - GuruFocus
Accelerate Diagnostics Appoints New Independent Directors - TipRanks
Accelerate Diagnostics board forms committee to exlore strategic alternatives - TipRanks
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - Yahoo Finance
Accelerate Diagnostics CTO sells shares worth $989 By Investing.com - Investing.com UK
Accelerate Diagnostics CTO sells shares worth $989 - Investing.com
Accelerate Diagnostics CEO Jack Phillips sells $16,472 in stock - Investing.com
Accelerate Diagnostics CEO Sells Shares to Cover Tax Obligations - TradingView
AXDX stock touches 52-week low at $0.63 amid market challenges - Investing.com India
Microbial Identification Methods Market Forecasted to Grow at 6.64% CAGR, Reaching $8.16 Billion by 2030The Insight Partners - Yahoo Finance
Automotive Diagnostics Scanner Market to Accelerate Growth with Actron, Denso, Launch Tech - newstrail.com
Accelerate Diagnostics CFO sells shares worth $4,839 By Investing.com - Investing.com South Africa
Finanzdaten der Accelerate Diagnostics Inc-Aktie (AXDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):